SOPHiA GENETICS
SOPH
32 hedge funds and large institutions have $43.2M invested in SOPHiA GENETICS in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 4 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.78% less ownership
Funds ownership: 27.82% → 26.05% (-1.8%)
6% less funds holding
Funds holding: 34 → 32 (-2)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
46% less capital invested
Capital invested by funds: $80.2M → $43.2M (-$37M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$998K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$315K |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$254K |
| 4 |
BPC
Banque Pictet & Cie
Geneva 73,
Switzerland
|
+$159K |
| 5 |
Morgan Stanley
New York
|
+$43.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.29M |
| 2 |
PVI
Pura Vida Investments
New York
|
-$1.03M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$323K |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$308K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$174K |
SOPH Hedge Fund Activity: Q3 2023 in Review
32 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q3 2023, worth a combined $43.2M — down 46% from $80.2M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SOPH and 2 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 9 added.
The largest buyer was Millennium Management, adding an estimated $998K. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $4.29M sold.
- 32 institutional investors held SOPHiA GENETICS (SOPH) as of Q3 2023, down from 34 in Q2 2023.
- Funds reported $43.2M of SOPHiA GENETICS stock for Q3 2023, down 46% quarter-over-quarter.
- 2 funds opened new SOPHiA GENETICS positions in Q3 2023 and 4 closed out, a net change of -2 holders.
- The largest SOPHiA GENETICS buyer in Q3 2023 was Millennium Management, an estimated $998K added.
- The largest SOPHiA GENETICS seller in Q3 2023 was T. Rowe Price Associates, an estimated $4.29M sold.
Based on aggregated 13F filings for Q3 2023.